The latest price of imported lenvatinib/lenvatinib in 2024

Lenvatinib is approved by the U.S. Food and Drug Administration (FDA) for the treatment of radioiodine-refractory differentiated thyroid cancer (DTC), unresectable or advanced hepatocellular carcinoma (HCC), advanced renal cell carcinoma (RCC), and endometrial cancer (EC). It is a multi-receptor tyrosine kinase inhibitor with potent anti-angiogenic properties. Inhibiting VEGF receptors prevents tumor angiogenesis, and inhibiting FGFR, RET, PDGFRa, and KIT prevents further proliferation of malignant cells.

Lenvatinib is an oral capsule that is usually taken once a day under the guidance of a doctor. It can be taken with or without food. Take lenvatinib at about the same time every day. Do not take too much or too little or more often than prescribed by your doctor. Swallow capsules whole; do not open, chew, or crush them. If the patient is unable to swallow lenvatinib capsules, they can be dissolved in edema and taken under the guidance of a doctor, or they can be administered through certain types of feeding tubes. Continue taking lenvatinib even if you feel well.

The original drug of lenvatinib has been launched in China and entered Class B medical insurance. The common specifications are:10mg*10 tablets*3 tablets, 4mg*10 tablets*3 tablets. The price of each box may range from 3,000 to 7,000 yuan; the price of each box of the original drug sold overseas may range from 1,000 to 3,000 yuan (the price may fluctuate due to the exchange rate). In addition, lenvatinib generic drugs are also produced and sold overseas. The drug ingredients are basically the same as the original drug, but the price is more affordable. Based on the specifications produced by Bangladesh Pharmaceutical Factory4mg*30 tablets, the price per box may be about 800 yuan (the price may fluctuate due to exchange rate effects).